Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Oberneder, R
CATUNIBLA, NCT04819399: Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC	Recruiting	1	30	Europe	Catumaxomab	Lindis Biotech GmbH	Urinary Bladder Neoplasms	12/22	12/23
Oberneder, Ralph
CATUNIBLA, NCT04819399: Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC	Recruiting	1	30	Europe	Catumaxomab	Lindis Biotech GmbH	Urinary Bladder Neoplasms	12/22	12/23